Replies to post #2721 on ScripsAmerica Inc. (SCRCQ)

[Talc Moan]

Yes! If Shareholders do not already know! SCRC is already generating Millions of dollars in Revenue!

Based on a Projected 10 million+ gross this Year the company is easily Valued at 2.75 a share with a 58 mill O/S!


8 million Float folks! Doing 10 mill+ a year!


There is ZERO reason SCRC will be on OTCBB much longer.

Amex+ is coming in 2014!

[The Claw]

I had not even thought about the potential for up listing. The revenues and market cap will surely be there for potential uplist that is almost certain. Gonna be a fun ride into the fall as well see more and more developments unfold

[tryz]

well spoken Celts.....this is already the foundation thats in place for ScripsAmerica > SCRC ,future catalysts with RapiMeds marketing roll-out and worlwide distribution in the coming months ignites and propels future revenue numbers beyong anyone's imagination and the pps will reflect it......keep those shares locked up and watch it unfold!....after many many years of investment trading a real rare find ground floor gem > THIS ONE IS THE ONE YOU ALL CALL: "A KEEPER".........imo,tryz

[pipedream1]

Spot on celtics! Would you trade a glaxo type company knowing what we know now. See the forest through the trees guys. This is a rare opportunity. Making change off it is a shame of what the big pictire could bring.

[tutter18]

Good morning SCRCers, Awesome post Celtics love the share structure, locked float and the revenues and especially Rapimeds getting ready to hit the big markets!!!! Shocknawe!!! SCRC! Tut

[Guts]

Okay Celtics, I ran to the board to see what you posted. Info provided is awesome and eye opening for those who weren't thinking in terms of revenues. The $2.75 projection is also exciting to see.

Everyone needs to keep in mind wholesalers like McKesson do not make any money based on what's in their warehouse. These wholesalers have a fully staffed team of sales reps who are responsible for taking warehouse inventory to pharmacy shelves. These are some of the most aggressive sales reps in the industry. They fight for retail shelf space as well as space on the medicine shelves. And, they are motivated by huge commission dollars. Distribution is just one aspect of product success. The other is physician's impression of the product and delivery system. As I wrote about before, compliance is a big concern for physicians and RapiMeds is the solution to that concern.

Once the product is on the shelves revenues will begin to SOAR! Demand = production = increased revenues!!! Go SCRC!!!

[Lovely Matilda]

If u have anymore THIS IS IT!!!!

[Talc Moan]

Repost Celts SCRC Valuation!

I WANT TO GET AWAY HROM THE TRADING AND LET THE ENTIRE BOARD KNOW THAT SCRC DOES REAL REVENUES NOW!!!!!!!! SCRC DOES 8M CURRENTLY IS IS PROJECTED TO DO OVER 10M IN REVENUES THIS YEAR!!

COMPANIES IN THIS SPACE TRADE AT 15X REVENUES!!!!! WE ARE TRADING RIGHT NOW 24M CAP THATS 60M SHARES OUTSTANDING X CURRENT PRICE .40 IS 24M MARKET CAP. IF WE DO 10M THIS YEAR ALREADY WE D 8M IN REVENUES THEN WE CAN GO ON THE AMEX AND VALUES SCRC AT $2.75 A SHARE.